Literature DB >> 12163417

Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland.

Gang Li1, Gertraud W Robinson, Ralf Lesche, Hilda Martinez-Diaz, Zhaorong Jiang, Nora Rozengurt, Kay-Uwe Wagner, De-Chang Wu, Timothy F Lane, Xin Liu, Lothar Hennighausen, Hong Wu.   

Abstract

PTEN tumor suppressor is frequently mutated in human cancers, including breast cancers. Female patients with inherited PTEN mutations suffer from virginal hypertrophy of the breast with high risk of malignant transformation. However, the exact mechanisms of PTEN in controlling mammary gland development and tumorigenesis are unclear. In this study, we generated mice with a mammary-specific deletion of the Pten gene. Mutant mammary tissue displayed precocious lobulo-alveolar development, excessive ductal branching, delayed involution and severely reduced apoptosis. Pten null mammary epithelial cells were disregulated and hyperproliferative. Mutant females developed mammary tumors early in life. Similar phenotypes were observed in Pten-null mammary epithelia that had been transplanted into wild-type stroma, suggesting that PTEN plays an essential and cell-autonomous role in controlling the proliferation, differentiation and apoptosis of mammary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163417     DOI: 10.1242/dev.129.17.4159

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  110 in total

Review 1.  Genetic alterations of PTEN in human melanoma.

Authors:  Almass-Houd Aguissa-Touré; Gang Li
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  Targeted expression of GLI1 in the salivary glands results in an altered differentiation program and hyperplasia.

Authors:  Marie Fiaschi; Asa Kolterud; Mats Nilsson; Rune Toftgård; Björn Rozell
Journal:  Am J Pathol       Date:  2011-09-18       Impact factor: 4.307

3.  Altered differentiation and paracrine stimulation of mammary epithelial cell proliferation by conditionally activated Smoothened.

Authors:  Adriana P Visbal; Heather L LaMarca; Hugo Villanueva; Michael J Toneff; Yi Li; Jeffrey M Rosen; Michael T Lewis
Journal:  Dev Biol       Date:  2011-01-27       Impact factor: 3.582

Review 4.  Apoptosis regulation in the mammary gland.

Authors:  K A Green; C H Streuli
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

Review 5.  Microarray analysis of the involution switch.

Authors:  Richard W E Clarkson; Christine J Watson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

Review 6.  Mouse models of inherited cancer syndromes.

Authors:  Sohail Jahid; Steven Lipkin
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

7.  Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions.

Authors:  Kulandayan K Subramanian; Yonghui Jia; Daocheng Zhu; Benjamin T Simms; Hakryul Jo; Hidenori Hattori; Jian You; Joseph P Mizgerd; Hongbo R Luo
Journal:  Blood       Date:  2007-01-03       Impact factor: 22.113

8.  Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth.

Authors:  Triparna Ghosh-Choudhury; Chandi C Mandal; Kathleen Woodruff; Patricia St Clair; Gabriel Fernandes; Goutam G Choudhury; Nandini Ghosh-Choudhury
Journal:  Breast Cancer Res Treat       Date:  2008-10-26       Impact factor: 4.872

9.  Ptch1 is required locally for mammary gland morphogenesis and systemically for ductal elongation.

Authors:  Ricardo C Moraes; Hong Chang; Nikesha Harrington; John D Landua; Jonathan T Prigge; Timothy F Lane; Brandon J Wainwright; Paul A Hamel; Michael T Lewis
Journal:  Development       Date:  2009-03-18       Impact factor: 6.868

10.  Distinct roles of the three Akt isoforms in lactogenic differentiation and involution.

Authors:  Ioanna G Maroulakou; William Oemler; Stephen P Naber; Ina Klebba; Charlotte Kuperwasser; Philip N Tsichlis
Journal:  J Cell Physiol       Date:  2008-11       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.